title: Complete radiologic response and long-term survival with use of systemic high-dose methotrexate for breast cancer-associated leptomeningeal disease.
authors.affiliation: Department of Medical Oncology, The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA.
authors.forename: Cesar A
authors.initials: CA
authors.lastname: Santa-Maria
authors.forename: Ashley
authors.initials: A
authors.lastname: Cimino-Mathews
authors.forename: Kendall F
authors.initials: KF
authors.lastname: Moseley
authors.forename: Antonio C
authors.initials: AC
authors.lastname: Wolff
authors.forename: Jaishri O
authors.initials: JO
authors.lastname: Blakeley
authors.forename: Roisin M
authors.initials: RM
authors.lastname: Connolly
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D001943:Breast Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D018275:Carcinoma, Lobular / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008279:Magnetic Resonance Imaging; D008577:Meningeal Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000556:secondary; D008727:Methotrexate / Q000008:administration & dosage*; D008875:Middle Aged; D011859:Radiography; D012074:Remission Induction / Q000379:methods; D017741:Survivors
chemical_list: D000964:Antimetabolites, Antineoplastic; D008727:Methotrexate